72 research outputs found

    Collaborating Across NU for Accessible Video

    Get PDF
    Recent budget trends have led to more collaboration across university systems. These collaborations help members solve common problems, share resources, and develop and support innovative initiatives beyond what individual institutions could do alone. Historically, higher education institutions have fallen behind in ensuring accessibility for teaching and learning systems in general, and specifically for video. In the past several years, the University of Nebraska campuses have seen an increased need to meet accessibility requirements for video, particularly in online courses. In this session, members of ITS from each campus will present processes and outcomes that led to selecting ilos as the system-wide tool for video storage and captioning. Ilos allows NU to focus on pedagogical design and instructional support for our faculty, while the system takes care of the infrastructure and workflow needed to ensure we meet accessibility standards. This session will also outline the strategies employed to make a system-wide decision, describe the benefits for faculty and students, and explain the leadership lessons learned

    Collaborating Across NU for Accessible Video

    Get PDF
    Recent budget trends have led to more collaboration across university systems. These collaborations help members solve common problems, share resources, and develop and support innovative initiatives beyond what individual institutions could do alone. Historically, higher education institutions have fallen behind in ensuring accessibility for teaching and learning systems in general, and specifically for video. In the past several years, the University of Nebraska campuses have seen an increased need to meet accessibility requirements for video, particularly in online courses. In this session, members of ITS from each campus will present processes and outcomes that led to selecting ilos as the system-wide tool for video storage and captioning. Ilos allows NU to focus on pedagogical design and instructional support for our faculty, while the system takes care of the infrastructure and workflow needed to ensure we meet accessibility standards. This session will also outline the strategies employed to make a system-wide decision, describe the benefits for faculty and students, and explain the leadership lessons learned

    Divergent evolution of protein conformational dynamics in dihydrofolate reductase.

    Get PDF
    Molecular evolution is driven by mutations, which may affect the fitness of an organism and are then subject to natural selection or genetic drift. Analysis of primary protein sequences and tertiary structures has yielded valuable insights into the evolution of protein function, but little is known about the evolution of functional mechanisms, protein dynamics and conformational plasticity essential for activity. We characterized the atomic-level motions across divergent members of the dihydrofolate reductase (DHFR) family. Despite structural similarity, Escherichia coli and human DHFRs use different dynamic mechanisms to perform the same function, and human DHFR cannot complement DHFR-deficient E. coli cells. Identification of the primary-sequence determinants of flexibility in DHFRs from several species allowed us to propose a likely scenario for the evolution of functionally important DHFR dynamics following a pattern of divergent evolution that is tuned by cellular environment

    Current and projected burden of heart failure in the Australian adult population: A substantive but still ill-defined major health issue

    Get PDF
    Background: Comprehensive epidemiological data to describe the burden of heart failure (HF) in Australia remain lacking despite its importance as a major health issue. Herewith, we estimate the current and future burden of HF in Australia using best available data

    Whitefield News

    Get PDF
    File includes January 2015 Volume 2, Issue 7 February 2015 Volume 2, Issue 8 March 2015 Volume 2, Issue 9 April 2015 Volume 2, Issue 10 May 2015 Volume 2, Issue 11 June 2015 Volume 2, Issue 12 July 2015 Volume 3, Issue 1 August 2015 Volume 3, Issue 2 September 2015, Volume 3, Issue 3 October 2015, Volume 3, Issue 4 November 2015, Volume 3, Issue 5 December 2015, Volume 3, Issue

    Functional neurological disorder is a feminist issue

    Get PDF
    Functional neurological disorder (FND) is a common and disabling disorder, often misunderstood by clinicians. Although viewed sceptically by some, FND is a diagnosis that can be made accurately, based on positive clinical signs, with clinical features that have remained stable for over 100 years. Despite some progress in the last decade, people with FND continue to suffer subtle and overt forms of discrimination by clinicians, researchers and the public. There is abundant evidence that disorders perceived as primarily affecting women are neglected in healthcare and medical research, and the course of FND mirrors this neglect. We outline the reasons why FND is a feminist issue, incorporating historical and contemporary clinical, research and social perspectives. We call for parity for FND in medical education, research and clinical service development so that people affected by FND can receive the care they need

    Conduit artery structure and function in lowlanders and native highlanders: relationships with oxidative stress and role of sympathoexcitation

    Get PDF
    Research detailing the normal vascular adaptions to high altitude is minimal and often confounded by pathology (e.g. chronic mountain sickness) and methodological issues. We examined vascular function and structure in: (1) healthy lowlanders during acute hypoxia and prolonged ( 2 weeks) exposure to high altitude, and (2) high-altitude natives at 5050 m (highlanders). In 12 healthy lowlanders (aged 32 ± 7 years) and 12 highlanders(Sherpa; 33 ± 14 years) we assessed brachial endothelium-dependent flow-mediated dilatation(FMD), endothelium-independent dilatation (via glyceryl trinitrate; GTN), common carotid intima–media thickness (CIMT) and diameter (ultrasound), and arterial stiffness via pulse wave velocity (PWV; applanation tonometry). Cephalic venous biomarkers of free radical-mediated lipid peroxidation (lipid hydroperoxides, LOOH), nitrite (NO2 –) and lipid soluble antioxidants were also obtained at rest. In lowlanders, measurements were performed at sea level (334 m) and between days 3–4 (acute high altitude) and 12–14 (chronic high altitude) following arrival to 5050 m. Highlanders were assessed once at 5050 m. Compared with sea level, acute high altitude reduced lowlanders’ FMD (7.9 ± 0.4 vs. 6.8 ± 0.4%; P = 0.004) and GTN-induced dilatation (16.6 ± 0.9 vs. 14.5 ± 0.8%; P = 0.006), and raised central PWV (6.0 ± 0.2 vs. 6.6 ± 0.3 m s−1; P = 0.001). These changes persisted at days 12–14, and after allometricallyscaling FMD to adjust for altered baseline diameter. Compared to lowlanders at sea level and high altitude, highlanders had a lower carotid wall:lumen ratio ( 19%, P 0.04), attributable to a narrower CIMT and wider lumen. Although both LOOH and NO2 – increased with high altitude in lowlanders, only LOOH correlated with the reduction in GTN-induced dilatation evident during acute (n = 11, r=−0.53) and chronic (n = 7, r=−0.69; P 0.01) exposure to 5050 m. In a follow-up, placebo-controlled experiment (n=11 healthy lowlanders) conducted in a normobaric hypoxic chamber (inspiredO2 fraction (FIO2 )=0.11; 6 h), a sustained reduction in FMD was evident within 1 h of hypoxic exposure when compared to normoxic baseline (5.7±1.6 vs. 8.0 ±1.3%; P < 0.01); this decline in FMD was largely reversed following α1-adrenoreceptor blockade. In conclusion, high-altitude exposure in lowlanders caused persistent impairment in vascular function, which was mediated partially via oxidative stress and sympathoexcitation. Although a lifetime of high-altitude exposure neither intensifies nor attenuates the impairments seen with short-term exposure, chronic high-altitude exposure appears to be associated with arterial remodelling

    Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.

    Get PDF
    Advances in the surgical management of the axilla in patients treated with neoadjuvant chemotherapy, especially those with node positive disease at diagnosis, have led to changes in practice and more judicious use of axillary lymph node dissection that may minimize morbidity from surgery. However, there is still significant confusion about how to optimally manage the axilla, resulting in variation among practices. From the viewpoint of drug development, assessment of response to neoadjuvant chemotherapy remains paramount and appropriate assessment of residual disease-the primary endpoint of many drug therapy trials in the neoadjuvant setting-is critical. Therefore decreasing the variability, especially in a multicenter clinical trial setting, and establishing a minimum standard to ensure consistency in clinical trial data, without mandating axillary lymph node dissection, for all patients is necessary. The key elements which include proper staging and identification of nodal involvement at diagnosis, and appropriately targeted management of the axilla at the time of surgical resection are presented. The following protocols have been adopted as standard procedure by the I-SPY2 trial for management of axilla in patients with node positive disease, and present a framework for prospective clinical trials and practice
    • …
    corecore